Speakers

Ryan Hartmaier, Ph.D. is a seasoned leader in translational medicine and biomarker strategy with over 20 years of experience in oncology drug development.

As Senior Director at AstraZeneca, he heads global translational strategy for the EGFR-mutated NSCLC franchise, driving innovative biomarker approaches that inform trial design and clinical development decisions. Ryan has a strong track record of delivering impactful translational insights across pre-IND, late-phase, and post-marketing programs, leveraging expertise in bioinformatics, molecular biology, and data science. His work has led to high-impact publications, foundational ctDNA datasets, and recognition as an expert among academic and industry peers.

Prior to AstraZeneca, Ryan held leadership roles at Foundation Medicine, contributing to major advances in cancer genomics and precision medicine. He earned his Ph.D. in Translational Biology and Molecular Medicine from Baylor College of Medicine and a B.S. in Bioengineering from the University of Washington.